Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has shared an update.
ASKA Pharmaceutical Holdings Co., Ltd. reported its consolidated financial results for the third quarter of FY2024, showing a slight increase in net sales to 49,926 million yen but a decrease in operating and ordinary profits. The profit attributable to owners of the parent dropped significantly by 36.5% compared to the previous year. Despite the decline in profits, the company’s total assets and equity ratio improved, indicating a stable financial position. The company has maintained its dividend forecast and expects a slight overall improvement in operating profit for the full fiscal year.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. is a company listed on the Tokyo Stock Exchange, focusing on the pharmaceutical industry. It is involved in the development and sale of pharmaceutical products and services.
YTD Price Performance: -6.29%
Average Trading Volume: 58,094
Technical Sentiment Consensus Rating: Hold
Current Market Cap: Yen55.89B
Learn more about 4886 stock on TipRanks’ Stock Analysis page.